by I. Edwards
The makers of two common weight-loss medicine—Wegovy and Zepbound—are chopping costs to make the medicines extra reasonably priced for folks with out insurance coverage.
Novo Nordisk, the Danish firm behind Wegovy, introduced Wednesday that it has lowered its month-to-month price by 23%. The brand new value—$499 monthly—takes impact instantly. It had been $650 a month.
The cheaper price is offered to each uninsured sufferers and folks whose insurance coverage doesn’t cowl weight-loss medicine, the corporate additionally stated.
Final week, Eli Lilly, the maker of Zepbound, additionally minimize costs for its starter dose to $349 monthly.
Bigger doses will now price $499 monthly by the corporate’s self-pay program.
Individuals utilizing these GLP-1 meds begin with smaller doses and progressively improve to increased quantities over time.
The value cuts come as provide points ease. Each medicines have lately been faraway from the U.S. Meals and Drug Administration’s scarcity record, permitting the businesses to fulfill rising demand.
Because of this, compounding pharmacies, which had been allowed to make off-brand variations in the course of the scarcity, might want to wind down manufacturing.
Each Wegovy and Zepbound belong to a category of medication which were proven to assist folks shed pounds by decreasing urge for food and growing the sentiments of fullness.
Extra info:
The Mayo Clinic has extra on prescription weight-loss medicine.
© 2025 HealthDay. All rights reserved.
Quotation:
Makers of Wegovy and Zepbound minimize costs for these with out insurance coverage (2025, March 7)
retrieved 8 March 2025
from https://medicalxpress.com/information/2025-03-makers-wegovy-zepbound-prices.html
This doc is topic to copyright. Other than any honest dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is offered for info functions solely.
